You are here: Industry Insights > FairJourney Biologics

News List

IONTAS Identifies Novel SARS-CoV-2 Neutralizing Antibodies americanpharmaceuticalreview
March 26, 2021
IONTAS and FairJourney Biologics have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants.
FairJourney Biologics, IONTAS enter antibody discovery pact with Pandion Therapeutics expresspharma
November 24, 2020
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research.
IONTAS and FairJourney Biologics find COVID-19 neutralizing antibodies with picomolar potency expresspharma
September 30, 2020
This viral neutralization efficiency was independently verified by the National Institute for Biological Standards and Control.
FairJourney Biologics Joins Forces with Iontas contractpharma
May 14, 2020
FairJourney Biologics and Iontas, two Clinical Research Organizations (CROs) in antibody discovery services, have combined their operations to create an international platform and provide their industry leading services to global biopharma.